A detailed history of First Turn Management, LLC transactions in Merus N.V. stock. As of the latest transaction made, First Turn Management, LLC holds 308,014 shares of MRUS stock, worth $13 Million. This represents 2.44% of its overall portfolio holdings.

Number of Shares
308,014
Previous 321,906 4.32%
Holding current value
$13 Million
Previous $19 Billion 19.21%
% of portfolio
2.44%
Previous 3.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$47.19 - $58.84 $655,563 - $817,405
-13,892 Reduced 4.32%
308,014 $15.4 Billion
Q2 2024

Aug 07, 2024

BUY
$39.81 - $60.2 $12.8 Million - $19.4 Million
321,906 New
321,906 $19 Billion

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $1.93B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track First Turn Management, LLC Portfolio

Follow First Turn Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Turn Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Turn Management, LLC with notifications on news.